Takashi Nagai
Papers
2
Total Citations
28
H-Index
2
About
Dr. Takashi Nagai is a pioneering translational researcher whose work sits at the intersection of regenerative medicine and oncology, with a particular focus on urological cancers and tissue repair. His most impactful contribution to date involves the biofabrication of functional urinary bladders, where he demonstrated the use of bone marrow-derived cells and a three-dimensional bioprinting robot system to successfully reconstruct damaged tissue in radiation-injured rat bladders. This 2018 study, which has garnered 24 citations, represents a critical early step toward developing regenerative therapies for patients suffering from radiation cystitis. More recently, Dr. Nagai has turned his attention to the chemopreventive potential of natural compounds. In his 2025 preliminary clinical study, he investigated the safety and efficacy of luteolin, a dietary flavonoid, for prostate cancer patients under active surveillance. This work builds on his prior foundational research into luteolin’s chemotherapeutic properties, offering a promising, low-toxicity intervention for men managing early-stage disease. Through these dual avenues—tissue engineering and nutraceutical oncology—Dr. Nagai is forging new paths for both repairing radiation damage and preventing cancer progression.
Research Focus
Key Achievements
Top Papers
- 1
- 2